This site is intended for healthcare professionals
News

BrainStorm Therapeutics announces topline results from NurOwn phase III ALS study

Read time: 1 mins
Last updated:18th Nov 2020
Published:18th Nov 2020
Condition: Amyotrophic Lateral Sclerosis
Type: drug
Register free for full access to medthority.com